Low TREM1 expression in whole blood predicts anti-TNF response in inflammatory bowel disease

Bram Verstockt(Universitair Ziekenhuis Leuven), Marc Ferrante(Universitair Ziekenhuis Leuven), Séverine Vermeire(KU Leuven), Christine Breynaert(KU Leuven), Vera Ballet(KU Leuven), Gert Van Assche(KU Leuven), Helene Blevi(KU Leuven), Willem-Jan Wollants(KU Leuven), Sare Verstockt(KU Leuven), Jonas Dehairs(KU Leuven)
EBioMedicine
January 27, 2019
10.1016/j.ebiom.2019.01.027
Cited by 173

Related Papers

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
|New England Journal of Medicine|2013|2.9k
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
|Nature Genetics|2008|2.6k
A decrease of the butyrate-producing species <i>Roseburia hominis</i> and <i>Faecalibacterium prausnitzii</i> defines dysbiosis in patients with ulcerative colitis
|Gut|2013|1.9k
ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications
|Journal of Crohn s and Colitis|2018|1.8k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k